- Main
Systems-based identification of the Hippo pathway for promoting fibrotic mesenchymal differentiation in systemic sclerosis.
- Ma, Feiyang;
- Tsou, Pei-Suen;
- Gharaee-Kermani, Mehrnaz;
- Plazyo, Olesya;
- Xing, Xianying;
- Kirma, Joseph;
- Wasikowski, Rachael;
- Hile, Grace;
- Harms, Paul;
- Jiang, Yanyun;
- Xing, Enze;
- Nakamura, Mio;
- Ochocki, Danielle;
- Brodie, William;
- Pillai, Shiv;
- Maverakis, Emanual;
- Pellegrini, Matteo;
- Modlin, Robert;
- Varga, John;
- Tsoi, Lam;
- Lafyatis, Robert;
- Kahlenberg, J;
- Billi, Allison;
- Khanna, Dinesh;
- Gudjonsson, Johann
- et al.
Published Web Location
https://doi.org/10.1038/s41467-023-44645-6Abstract
Systemic sclerosis (SSc) is a devastating autoimmune disease characterized by excessive production and accumulation of extracellular matrix, leading to fibrosis of skin and other internal organs. However, the main cellular participants in SSc skin fibrosis remain incompletely understood. Here using differentiation trajectories at a single cell level, we demonstrate a dual source of extracellular matrix deposition in SSc skin from both myofibroblasts and endothelial-to-mesenchymal-transitioning cells (EndoMT). We further define a central role of Hippo pathway effectors in differentiation and homeostasis of myofibroblast and EndoMT, respectively, and show that myofibroblasts and EndoMTs function as central communication hubs that drive key pro-fibrotic signaling pathways in SSc. Together, our data help characterize myofibroblast differentiation and EndoMT phenotypes in SSc skin, and hint that modulation of the Hippo pathway may contribute in reversing the pro-fibrotic phenotypes in myofibroblasts and EndoMTs.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.
Main Content
Enter the password to open this PDF file:
-
-
-
-
-
-
-
-
-
-
-
-
-
-